nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0659	0.12	CbGpPWpGaD
Naloxone—CREB1—nephron tubule—nephrolithiasis	0.0341	0.112	CbGeAlD
Naloxone—CREB1—renal system—nephrolithiasis	0.031	0.102	CbGeAlD
Naloxone—CREB1—kidney—nephrolithiasis	0.0299	0.0982	CbGeAlD
Naloxone—CREB1—cortex of kidney—nephrolithiasis	0.0291	0.0957	CbGeAlD
Naloxone—TLR4—Spinal Cord Injury—AQP1—nephrolithiasis	0.0285	0.052	CbGpPWpGaD
Naloxone—CYP3A4—urine—nephrolithiasis	0.0278	0.0912	CbGeAlD
Naloxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0263	0.048	CbGpPWpGaD
Naloxone—OPRD1—renal system—nephrolithiasis	0.0245	0.0803	CbGeAlD
Naloxone—OPRD1—kidney—nephrolithiasis	0.0237	0.0777	CbGeAlD
Naloxone—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.019	0.129	CcSEcCtD
Naloxone—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0159	0.108	CcSEcCtD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—RGS14—nephrolithiasis	0.0148	0.027	CbGpPWpGaD
Naloxone—SLCO1A2—renal system—nephrolithiasis	0.0144	0.0472	CbGeAlD
Naloxone—SLCO1A2—kidney—nephrolithiasis	0.0139	0.0456	CbGeAlD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—SPP1—nephrolithiasis	0.0133	0.0242	CbGpPWpGaD
Naloxone—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0826	CcSEcCtD
Naloxone—ESR1—renal system—nephrolithiasis	0.0122	0.04	CbGeAlD
Naloxone—ESR1—kidney—nephrolithiasis	0.0118	0.0387	CbGeAlD
Naloxone—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0735	CcSEcCtD
Naloxone—OPRD1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0106	0.0193	CbGpPWpGaD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.0104	0.0189	CbGpPWpGaD
Naloxone—CYP2C8—renal system—nephrolithiasis	0.01	0.033	CbGeAlD
Naloxone—CYP2C8—kidney—nephrolithiasis	0.00971	0.0319	CbGeAlD
Naloxone—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00947	0.0641	CcSEcCtD
Naloxone—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00939	0.0635	CcSEcCtD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00931	0.017	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00926	0.0169	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00851	0.0155	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00851	0.0155	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00783	0.0143	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00769	0.014	CbGpPWpGaD
Naloxone—CYP3A4—renal system—nephrolithiasis	0.0068	0.0223	CbGeAlD
Naloxone—CYP3A4—kidney—nephrolithiasis	0.00657	0.0216	CbGeAlD
Naloxone—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00654	0.0443	CcSEcCtD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00645	0.0118	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00645	0.0118	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.006	0.011	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.006	0.011	CbGpPWpGaD
Naloxone—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00569	0.0385	CcSEcCtD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00556	0.0101	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00535	0.00976	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00531	0.00969	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00531	0.00969	CbGpPWpGaD
Naloxone—ABCB1—nephron tubule—nephrolithiasis	0.0053	0.0174	CbGeAlD
Naloxone—Tension—Hydrochlorothiazide—nephrolithiasis	0.00523	0.0354	CcSEcCtD
Naloxone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00518	0.0351	CcSEcCtD
Naloxone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.005	0.0338	CcSEcCtD
Naloxone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0049	0.0332	CcSEcCtD
Naloxone—ABCB1—renal system—nephrolithiasis	0.00481	0.0158	CbGeAlD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00479	0.00874	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00473	0.00864	CbGpPWpGaD
Naloxone—ABCB1—kidney—nephrolithiasis	0.00465	0.0153	CbGeAlD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00455	0.0083	CbGpPWpGaD
Naloxone—ABCB1—cortex of kidney—nephrolithiasis	0.00453	0.0149	CbGeAlD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00433	0.0079	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00433	0.0079	CbGpPWpGaD
Naloxone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00425	0.0288	CcSEcCtD
Naloxone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00421	0.0285	CcSEcCtD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0042	0.00767	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00416	0.00759	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00416	0.00759	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0041	0.00749	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.0041	0.00749	CbGpPWpGaD
Naloxone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00391	0.0265	CcSEcCtD
Naloxone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00388	0.0263	CcSEcCtD
Naloxone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00372	0.0252	CcSEcCtD
Naloxone—OPRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00362	0.0066	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0036	0.00657	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00355	0.00648	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—SPP1—nephrolithiasis	0.00352	0.00642	CbGpPWpGaD
Naloxone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00344	0.0233	CcSEcCtD
Naloxone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00344	0.0233	CcSEcCtD
Naloxone—CREB1—Signaling by GPCR—RGS14—nephrolithiasis	0.00329	0.00601	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.00328	0.00599	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00328	0.00599	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00328	0.00599	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00317	0.00579	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00315	0.00576	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00315	0.00576	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00312	0.0057	CbGpPWpGaD
Naloxone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00312	0.0211	CcSEcCtD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00305	0.00557	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00305	0.00557	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00304	0.00555	CbGpPWpGaD
Naloxone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00298	0.0202	CcSEcCtD
Naloxone—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00297	0.00543	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00293	0.00535	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00293	0.00535	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—SPP1—nephrolithiasis	0.00292	0.00532	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—RGS14—nephrolithiasis	0.00288	0.00526	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—PTH—nephrolithiasis	0.00286	0.00522	CbGpPWpGaD
Naloxone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00277	0.0187	CcSEcCtD
Naloxone—OPRK1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00274	0.005	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00272	0.00496	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00272	0.00496	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00268	0.00489	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00261	0.00477	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00259	0.00473	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00259	0.00473	CbGpPWpGaD
Naloxone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00259	0.0175	CcSEcCtD
Naloxone—OPRK1—GPCR ligand binding—PTH—nephrolithiasis	0.00251	0.00458	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00244	0.00446	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00243	0.00444	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00232	0.00423	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00231	0.00422	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ADCY10—nephrolithiasis	0.00229	0.00418	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.00228	0.00416	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00227	0.00415	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00227	0.00415	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—DGKH—nephrolithiasis	0.00222	0.00406	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.00222	0.00405	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.0022	0.00402	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00217	0.00397	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00214	0.00391	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—PTH—nephrolithiasis	0.00212	0.00387	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00211	0.00386	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00211	0.00386	CbGpPWpGaD
Naloxone—CREB1—Disease—SLC26A1—nephrolithiasis	0.00211	0.00384	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00202	0.0037	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ADCY10—nephrolithiasis	0.002	0.00365	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RGS14—nephrolithiasis	0.00195	0.00355	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—DGKH—nephrolithiasis	0.00194	0.00355	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RGS14—nephrolithiasis	0.00194	0.00354	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GRHPR—nephrolithiasis	0.00188	0.00344	CbGpPWpGaD
Naloxone—CREB1—Disease—ATP6V0A4—nephrolithiasis	0.00188	0.00343	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00185	0.00338	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00185	0.00338	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00181	0.0033	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00177	0.00322	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RGS14—nephrolithiasis	0.0017	0.00311	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.00169	0.00309	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—AGXT—nephrolithiasis	0.00168	0.00307	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.00164	0.003	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.00161	0.00295	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00161	0.00294	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.0016	0.00293	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0016	0.00292	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0016	0.00292	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00155	0.00283	CbGpPWpGaD
Naloxone—ALB—Hemostasis—DGKH—nephrolithiasis	0.00153	0.0028	CbGpPWpGaD
Naloxone—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.00153	0.0028	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ADCY10—nephrolithiasis	0.0015	0.00274	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00149	0.00272	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00149	0.00272	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—PTH—nephrolithiasis	0.00147	0.00269	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—PTH—nephrolithiasis	0.00147	0.00268	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RGS14—nephrolithiasis	0.00144	0.00262	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC26A1—nephrolithiasis	0.00143	0.00261	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—APRT—nephrolithiasis	0.00143	0.00261	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—PTH—nephrolithiasis	0.00142	0.00259	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00141	0.00257	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0014	0.00256	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0014	0.00256	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00133	0.00242	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00133	0.00242	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00131	0.0024	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—DGKH—nephrolithiasis	0.00131	0.0024	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00131	0.00239	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—DGKH—nephrolithiasis	0.00131	0.00239	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00131	0.00239	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0013	0.00238	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0013	0.00238	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—PTH—nephrolithiasis	0.00129	0.00235	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RGS14—nephrolithiasis	0.00127	0.00233	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—PTH—nephrolithiasis	0.0012	0.00219	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00119	0.00217	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00116	0.00212	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00116	0.00212	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—DGKH—nephrolithiasis	0.00115	0.0021	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00115	0.0021	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PTH—nephrolithiasis	0.00109	0.00198	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00106	0.00194	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—AQP1—nephrolithiasis	0.00102	0.00186	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000971	0.00177	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—DGKH—nephrolithiasis	0.000971	0.00177	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CHRM3—nephrolithiasis	0.00095	0.00173	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000947	0.00173	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00093	0.0017	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000926	0.00169	CbGpPWpGaD
Naloxone—ALB—Metabolism—GRHPR—nephrolithiasis	0.00092	0.00168	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CHRM3—nephrolithiasis	0.00092	0.00168	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTH—nephrolithiasis	0.000869	0.00159	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTH—nephrolithiasis	0.000866	0.00158	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—DGKH—nephrolithiasis	0.000861	0.00157	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000861	0.00157	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CHRM3—nephrolithiasis	0.000831	0.00152	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000825	0.00151	CbGpPWpGaD
Naloxone—ALB—Metabolism—AGXT—nephrolithiasis	0.00082	0.0015	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000806	0.00147	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTH—nephrolithiasis	0.00076	0.00139	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000719	0.00131	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CHRM3—nephrolithiasis	0.000702	0.00128	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000701	0.00128	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000701	0.00128	CbGpPWpGaD
Naloxone—ALB—Metabolism—APRT—nephrolithiasis	0.000697	0.00127	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000697	0.00127	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTH—nephrolithiasis	0.000642	0.00117	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CHRM3—nephrolithiasis	0.000622	0.00114	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APRT—nephrolithiasis	0.000611	0.00112	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000611	0.00112	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTH—nephrolithiasis	0.000569	0.00104	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.0005	0.000913	CbGpPWpGaD
Naloxone—ALB—Metabolism—AQP1—nephrolithiasis	0.000497	0.000907	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000497	0.000907	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000452	0.000825	CbGpPWpGaD
Naloxone—ALB—Metabolism—CHRM3—nephrolithiasis	0.000449	0.000821	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000443	0.000809	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SPP1—nephrolithiasis	0.000436	0.000797	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000435	0.000795	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000435	0.000794	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000394	0.000719	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SPP1—nephrolithiasis	0.000381	0.000696	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000377	0.000688	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000377	0.000688	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SPP1—nephrolithiasis	0.000322	0.000588	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SPP1—nephrolithiasis	0.000286	0.000522	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000268	0.00049	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000243	0.000443	CbGpPWpGaD
